Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis-Reference-Cited by-同舟云学术

Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis

Published:2020-04-07 Issue:4 Volume:80 Page:313-317
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Agnello Luisa¹,Piccoli Tommaso²^ORCID,Vidali Matteo³,Cuffaro Luca²^ORCID,Lo Sasso Bruna¹^ORCID,Iacolino Giorgia¹,Giglio Vincenza Rosaria¹,Lupo Federica²,Alongi Pierpaolo²,Bivona Giulia¹^ORCID,Ciaccio Marcello¹⁴^ORCID

Affiliation:

1. Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy;

2. Unit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy;

3. Unit of Clinical Chemistry, Maggiore della Carità Hospital, Novara, Italy;

4. Department of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2020.1740939

Reference45 articles.

1. Alzheimer's disease

2. Alzheimer’s disease: risk factors and potentially protective measures